Therapeutics Acquisition Corp

Therapeutics Acquisition Corp, trading under the ticker PNT, is a blank-check company that filed its S-1 registration statement with the SEC on June 15, 2020, targeting the therapeutics and biopharmaceutical sector. The vehicle was structured to identify and merge with a company operating in the life-sciences and drug-development space, reflecting the wave of healthcare-focused SPACs that gained momentum during the 2020 SPAC boom. The filing, assigned accession number 0001047469-20-003606, initiated the company's path toward a public listing on the strength of its sector thesis at a time of elevated investor interest in biopharma innovation. Visit SpacDesk and sign up for full data, filings history, and deal-status tracking on PNT and hundreds of other SPAC vehicles.